A detailed history of Franklin Resources Inc transactions in Genmab A/S stock. As of the latest transaction made, Franklin Resources Inc holds 27,067 shares of GMAB stock, worth $716,734. This represents 0.0% of its overall portfolio holdings.

Number of Shares
27,067
Previous 30,650 11.69%
Holding current value
$716,734
Previous $916,000 25.76%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$25.13 - $30.27 $90,040 - $108,457
-3,583 Reduced 11.69%
27,067 $680,000
Q1 2024

May 13, 2024

BUY
$26.43 - $32.77 $7,902 - $9,798
299 Added 0.99%
30,650 $916,000
Q4 2023

Feb 09, 2024

SELL
$27.94 - $35.44 $14.7 Million - $18.7 Million
-527,256 Reduced 94.56%
30,351 $966,000
Q3 2023

Nov 13, 2023

SELL
$35.27 - $42.24 $3.1 Million - $3.72 Million
-88,030 Reduced 13.63%
557,607 $19.7 Million
Q2 2023

Aug 11, 2023

BUY
$37.4 - $42.94 $4.17 Million - $4.79 Million
111,451 Added 20.86%
645,637 $24.5 Million
Q1 2023

May 12, 2023

BUY
$34.88 - $43.22 $3.24 Million - $4.01 Million
92,824 Added 21.03%
534,186 $20.2 Million
Q4 2022

Feb 10, 2023

BUY
$33.8 - $47.06 $14.6 Million - $20.3 Million
431,763 Added 4498.0%
441,362 $18.7 Million
Q3 2022

Nov 14, 2022

SELL
$31.52 - $373.61 $5,484 - $65,008
-174 Reduced 1.78%
9,599 $309,000
Q2 2022

Aug 11, 2022

BUY
$26.83 - $38.57 $89,665 - $128,900
3,342 Added 51.97%
9,773 $318,000
Q1 2022

May 13, 2022

SELL
$30.95 - $39.68 $12,999 - $16,665
-420 Reduced 6.13%
6,431 $233,000
Q4 2021

Feb 11, 2022

BUY
$35.87 - $47.12 $32,821 - $43,114
915 Added 15.41%
6,851 $271,000
Q3 2021

Nov 12, 2021

BUY
$41.55 - $48.72 $16,246 - $19,049
391 Added 7.05%
5,936 $259,000
Q2 2021

Aug 13, 2021

BUY
$32.88 - $44.57 $182,319 - $247,140
5,545 New
5,545 $226,000
Q1 2021

May 13, 2021

SELL
$30.92 - $44.4 $158,032 - $226,928
-5,111 Closed
0 $0
Q4 2020

Feb 10, 2021

BUY
$33.66 - $40.76 $172,036 - $208,324
5,111 New
5,111 $208,000

Others Institutions Holding GMAB

About GENMAB A/S


  • Ticker GMAB
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 658,292,992
  • Market Cap $17.4B
  • Description
  • Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...
More about GMAB
Track This Portfolio

Track Franklin Resources Inc Portfolio

Follow Franklin Resources Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.